Divi's Laboratories is in the process of entering into a long-term custom synthesis supply agreement with an MNC customer. The company is expected to maintain double-digit growth trajectory.
What is covered in the Full Insight:
Introduction
Company Overview
Q4FY24 Performance
Profitability Analysis
Future Outlook
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.